483
Daniel Fred Goodman, M.D.Daniel Fred Goodman, M.D. – FDA 483, Dec 13, 2021
Record Details
Daniel Fred Goodman, M.D., a sponsor-investigator in San Francisco, CA, was cited for multiple significant violations during an FDA inspection. The inspection revealed serious deficiencies in the conduct of a Phase 1 clinical investigation, primarily concerning informed consent procedures, protocol adherence, investigational drug accountability, and regulatory reporting. These issues indicate a severe lack of oversight and compliance with clinical trial regulations.
View Company Profile
ID · 317bef58-c03c-4dc7-b1c4-831ec0289166
Other documents for Daniel Fred Goodman, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.